Get started
Author

Miguel Valero

Observed names: M Valero, Valero, Miguel
Observed institution: Hospital Carlos Van Buren
OpenAlex ID: A5045632547
Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy‐induced nausea and vomiting in pediatric cancer patients
2019 · Jaume Mora, Miguel Valero, et al. · Pediatric Blood & Cancer · 16
Results of Therapy for Wilms Tumor and Other Malignant Kidney Tumors: A Report From the Chilean Pediatric National Cancer Program (PINDA)
2016 · Pilar Joannon, Ana Becker, et al. · Journal of Pediatric Hematology/Oncology · 10
Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile
2021 · Mohammad H. Abu-Arja, Nicolás Rojas del Río, et al. · JCO Global Oncology · 8
PDF
A multicentric study of interval compressed multiagent chemotherapy and metronomic chemotherapy for patients with Ewing sarcoma family of tumors: The Latin American Pediatric Oncology Group trial.
2015 · Lauro José Gregianin, Marcelo Scopinaro, et al. · Journal of Clinical Oncology · 5
Experiencia del Comité de Ética Asistencial del Hospital Carlos van Buren entre los años 2007-2020
2022 · Sebastián Vega, Santiago Parry, et al. · Revista médica de Chile · 3
Linc-21. Survey on the Resources Available for Pediatric Neuro-oncology in Chile, South America
2020 · Mohammad H Abu-Arja, Nicolás Rojas del Río, et al. · Neuro-Oncology
Result of therapy for Hodgkin Lymphoma (HL): a report from the Chilean pediatric National Cancer Program (PINDA)
2020 · E Concha, M Cordova, et al. · Klinische Pädiatrie
Pharmacokinetics/pharmacodynamics (PK/PD), safety, and tolerability of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting (CINV) in pediatric subjects.
2017 · Jaume Mora, Miguel Valero, et al. · Journal of Clinical Oncology
Works count: 9
Citation count: 42
H-index: 4
I10-index: 2
Year
Topic
Type